150 related articles for article (PubMed ID: 34871415)
41. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
Kim AW; Faber LP; Warren WH; Basu S; Wightman SC; Weber JA; Bonomi P; Liptay MJ
Ann Thorac Surg; 2009 Sep; 88(3):937-43; discussion 944. PubMed ID: 19699924
[TBL] [Abstract][Full Text] [Related]
42. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
[TBL] [Abstract][Full Text] [Related]
43. Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
Brandt WS; Yan W; Zhou J; Tan KS; Montecalvo J; Park BJ; Adusumilli PS; Huang J; Bott MJ; Rusch VW; Molena D; Travis WD; Kris MG; Chaft JE; Jones DR
J Thorac Cardiovasc Surg; 2019 Feb; 157(2):743-753.e3. PubMed ID: 30415902
[TBL] [Abstract][Full Text] [Related]
44. Pneumonectomy with en bloc chest wall resection: is it worthwhile? Report on 34 patients from two institutions.
Cardillo G; Spaggiari L; Galetta D; Carleo F; Carbone L; Morrone A; Ricci A; Facciolo F; Martelli M
Interact Cardiovasc Thorac Surg; 2013 Jul; 17(1):54-8. PubMed ID: 23529751
[TBL] [Abstract][Full Text] [Related]
45. Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer.
Takeda S; Maeda H; Okada T; Yamaguchi T; Nakagawa M; Yokota S; Sawabata N; Ohta M
Eur J Cardiothorac Surg; 2006 Jul; 30(1):184-9. PubMed ID: 16730452
[TBL] [Abstract][Full Text] [Related]
46. Does pneumonectomy for lung cancer adversely influence long-term survival?
Ferguson MK; Karrison T
J Thorac Cardiovasc Surg; 2000 Mar; 119(3):440-8. PubMed ID: 10694601
[TBL] [Abstract][Full Text] [Related]
47. Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients.
Yang CJ; Mayne NR; Wang H; Meyerhoff RR; Hirji S; Tong BC; Hartwig M; Harpole D; D'Amico TA; Berry M
Ann Thorac Surg; 2016 Sep; 102(3):962-970. PubMed ID: 27234579
[TBL] [Abstract][Full Text] [Related]
48. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study.
Ayub A; Rehmani SS; Al-Ayoubi AM; Raad W; Flores RM; Bhora FY
Ann Thorac Surg; 2017 Oct; 104(4):1131-1137. PubMed ID: 28709663
[TBL] [Abstract][Full Text] [Related]
49. Early discharge on postoperative day 1 following lobectomy for stage I non-small-cell lung cancer is safe in high-volume surgical centres: a national cancer database analysis.
Drawbert HE; Hey MT; Tarrazzi F; Block M; Razi SS
Eur J Cardiothorac Surg; 2022 May; 61(5):1022-1029. PubMed ID: 34849695
[TBL] [Abstract][Full Text] [Related]
50. Is sleeve lobectomy comparable in terms of short- and long-term results with pneumonectomy after induction therapy? A multicenter analysis.
Cusumano G; Marra A; Lococo F; Margaritora S; Siciliani A; Maurizi G; Poggi C; Hillejan L; Rendina E; Granone P
Ann Thorac Surg; 2014 Sep; 98(3):975-83. PubMed ID: 25038013
[TBL] [Abstract][Full Text] [Related]
51. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits.
Doddoli C; Barlesi F; Trousse D; Robitail S; Yena S; Astoul P; Giudicelli R; Fuentes P; Thomas P
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):416-25. PubMed ID: 16077407
[TBL] [Abstract][Full Text] [Related]
52. Completion pneumonectomy in patients with cancer: postoperative survival and mortality factors.
Tabutin M; Couraud S; Guibert B; Mulsant P; Souquet PJ; Tronc F
J Thorac Oncol; 2012 Oct; 7(10):1556-62. PubMed ID: 22982656
[TBL] [Abstract][Full Text] [Related]
53. Neo-adjuvant Chemo-Radiation to 60 Gray Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer Patients: Evaluation of Trimodality Strategy.
Appel S; Goldstein J; Perelman M; Rabin T; Urban D; Onn A; Shulimzon TR; Weiss I; Lieberman S; Marom EM; Golan N; Simansky D; Ben-Nun A; Lawrence YR; Bar J; Symon Z
Isr Med Assoc J; 2017 Oct; 19(10):614-619. PubMed ID: 29103238
[TBL] [Abstract][Full Text] [Related]
54. Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer.
Yang CF; Gulack BC; Gu L; Speicher PJ; Wang X; Harpole DH; Onaitis MW; D'Amico TA; Berry MF; Hartwig MG
J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1484-92; discussion 1492-3. PubMed ID: 26259994
[TBL] [Abstract][Full Text] [Related]
55. Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?
Joosten PJM; Dickhoff C; van der Noort V; Klomp HM; van Diessen JNA; Dahele M; Bahce I; Veenhof AAFA; Smit EF; Hartemink KJ
Lung Cancer; 2020 Dec; 150():209-215. PubMed ID: 33220611
[TBL] [Abstract][Full Text] [Related]
56. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy.
Martin J; Ginsberg RJ; Abolhoda A; Bains MS; Downey RJ; Korst RJ; Weigel TL; Kris MG; Venkatraman ES; Rusch VW
Ann Thorac Surg; 2001 Oct; 72(4):1149-54. PubMed ID: 11603428
[TBL] [Abstract][Full Text] [Related]
57. Predictors and outcomes of limited resection for early-stage non-small cell lung cancer.
Billmeier SE; Ayanian JZ; Zaslavsky AM; Nerenz DR; Jaklitsch MT; Rogers SO
J Natl Cancer Inst; 2011 Nov; 103(21):1621-9. PubMed ID: 21960708
[TBL] [Abstract][Full Text] [Related]
58. Sleeve lobectomy after induction chemoradiotherapy.
Gómez-Caro A; Boada M; Reguart N; Viñolas N; Casas F; Molins L
Eur J Cardiothorac Surg; 2012 May; 41(5):1052-8. PubMed ID: 22223693
[TBL] [Abstract][Full Text] [Related]
59. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
[TBL] [Abstract][Full Text] [Related]
60. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
Couñago F; Montemuiño S; Martin M; Taboada B; Calvo-Crespo P; Samper-Ots MP; Alcántara P; Corona J; López-Guerra JL; Murcia-Mejía M; López-Mata M; Jové-Teixidó J; Chust M; Díaz-Díaz V; de Ingunza-Barón L; García-Cañibano T; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Puertas MM; Thuissard IJ; Sanz-Rosa D; de Dios NR
Clin Transl Oncol; 2019 Jun; 21(6):735-744. PubMed ID: 30430394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
